<![CDATA[BaroPace, Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=43668>Sun, 03 May 2026 13:04:30 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[BaroPace, Inc. Announced First Patient Enrolled in Non-Pharmacologic Hypertension and Heart Failure Treatment Trial]]>https://www.newswire.co.kr/newsRead.php?no=972779Wed, 23 Aug 2023 10:30:00 +0900<![CDATA[바로페이스, 고혈압·심부전의 비약물적 치료 임상시험에 첫 환자 등록 발표]]>https://www.newswire.co.kr/newsRead.php?no=972782Wed, 23 Aug 2023 10:30:00 +0900<![CDATA[BaroPace Receives Approval for First-in-Human Clinical Trial]]>https://www.newswire.co.kr/newsRead.php?no=971290Wed, 26 Jul 2023 17:15:00 +0900<![CDATA[바로페이스, 최초의 인간 임상 시험 승인 획득]]>https://www.newswire.co.kr/newsRead.php?no=971291Wed, 26 Jul 2023 17:15:00 +0900